▁Chron 10.375
ic 5.49609375
▁p 8.953125
Y 9.625
ain 11.328125
▁is 6.39453125
▁still 6.859375
▁considered 7.6875
▁to 1.9169921875
▁be 0.6572265625
▁an 4.265625
▁extreme 6.71484375
▁issue 8.7890625
▁among 8.0390625
▁at 7.20703125
▁least 1.90625
▁ 2.966796875
8 3.341796875
% 4.2734375
▁of 1.8759765625
▁the 1.4599609375
▁residents 9.40625
▁of 2.50390625
▁progress 9.21875
ive 0.8759765625
▁countries 8.2265625
. 2.037109375
▁The 2.634765625
▁introduction 7.3203125
▁of 0.302001953125
▁the 1.6259765625
▁study 7.08203125
▁describes 7.78515625
▁the 0.890625
▁apparent 9.1953125
▁link 6.31640625
▁between 0.49072265625
▁pain 8.0546875
▁and 0.9951171875
▁dem 7.98828125
oral 3.15625
ization 0.3583984375
. 1.599609375
▁Chron 6.26171875
ic 0.06494140625
▁pain 0.50146484375
▁is 1.392578125
▁always 6.43359375
▁accompanied 1.830078125
▁by 0.048492431640625
▁negative 4.71484375
▁emot 1.3671875
ional 1.326171875
▁experiences 2.79296875
▁and 2.17578125
▁blocks 11.40625
▁a 4.16796875
▁person 1.4990234375
’ 25.03125
s 2.08203125
▁ability 1.58203125
▁to 0.043365478515625
▁receive 6.4296875
▁joy 5.1640625
▁and 1.3447265625
▁satisfaction 2.869140625
▁from 1.1181640625
▁life 1.0556640625
. 0.30517578125
▁The 1.9384765625
▁research 3.919921875
▁investig 5.06640625
ates 0.5634765625
▁the 0.47705078125
▁development 5.82421875
▁of 0.185302734375
▁de 3.9765625
pression 0.2374267578125
▁and 1.248046875
▁anx 2.322265625
iety 0.003871917724609375
▁among 2.412109375
▁patients 2.576171875
▁receiving 4.26953125
▁ph 6.88671875
arma 1.888671875
ce 0.00955963134765625
ut 0.0005044937133789062
ical 0.01047515869140625
▁op 4.53125
io 0.1640625
ids 0.65576171875
▁and 2.283203125
▁medical 6.14453125
▁mar 1.5615234375
iju 0.054046630859375
ana 0.00013387203216552734
▁( 4.30078125
MM 0.763671875
) 3.3671875
▁as 2.87109375
▁severe 9.9296875
▁pain 1.3525390625
kill 3.224609375
ers 0.0018405914306640625
. 0.55322265625
▁It 3.244140625
▁comp 4.99609375
ares 0.035614013671875
▁the 0.64892578125
▁effic 6.4296875
acy 0.00659942626953125
▁of 0.288330078125
▁pres 5.21875
cri 1.80078125
ptions 0.7568359375
▁and 2.220703125
▁exam 5.8671875
ines 0.01110076904296875
▁the 0.44091796875
▁possibility 3.900390625
▁of 0.11181640625
▁post 7.25
- 0.71923828125
tre 2.396484375
at 0.020721435546875
ment 0.006256103515625
▁de 1.859375
pression 0.1051025390625
. 1.7412109375
<0x0A> 2.1328125
There 4.9453125
▁is 1.0556640625
▁currently 4.59765625
▁a 1.26171875
▁severe 5.0
▁lack 3.39453125
▁of 0.021514892578125
▁information 2.09375
▁about 1.3369140625
▁the 0.45361328125
▁effects 2.80078125
▁of 0.07269287109375
▁op 1.7958984375
i 3.98046875
ates 0.12109375
. 3.84375
▁They 4.94921875
▁man 14.296875
a 4.890625
eg 3.50390625
▁pain 10.6875
▁successfully 7.60546875
, 1.283203125
▁but 0.337158203125
▁the 2.5859375
▁past 9.5859375
▁few 2.173828125
▁dec 0.84228515625
ades 0.001239776611328125
▁indicated 9.359375
▁the 2.171875
▁growing 4.6875
▁concern 3.5390625
▁regarding 3.34375
▁op 3.607421875
iate 0.7568359375
▁ab 1.525390625
use 0.0121307373046875
▁in 3.21875
▁forms 10.6953125
▁of 0.441162109375
▁over 3.31640625
d 0.392333984375
ose 0.1759033203125
▁and 0.7080078125
▁add 1.0869140625
iction 0.03167724609375
. 0.231689453125
▁A 3.93359375
▁more 5.6328125
▁manage 8.8046875
able 0.007480621337890625
▁an 7.0625
▁d 6.9296875
sa 4.1640625
fer 0.5947265625
▁alternative 2.017578125
▁might 6.6875
▁be 0.2105712890625
▁medical 2.6328125
▁mar 0.186767578125
iju 0.0248565673828125
ana 0.00708770751953125
. 1.455078125
▁However 3.001953125
, 0.0189361572265625
▁the 1.6220703125
▁legal 4.234375
▁status 1.1025390625
▁and 2.751953125
▁novel 9.4296875
ty 0.70654296875
▁o 9.1875
▁this 3.76953125
▁drug 2.314453125
▁do 4.98828125
▁not 0.1219482421875
▁allow 1.2353515625
▁finding 8.890625
▁a 2.326171875
▁large 4.14453125
▁number 1.2900390625
▁of 0.034210205078125
▁studies 1.4892578125
▁on 1.54296875
▁its 1.015625
▁effect 2.173828125
iveness 0.34619140625
. 1.029296875
▁Specifically 8.2265625
, 0.1685791015625
▁it 2.6015625
▁concerns 5.11328125
▁the 0.6357421875
▁em 9.6953125
otion 0.49365234375
l 6.1953125
▁condition 6.11328125
▁of 0.69287109375
▁patients 1.0712890625
▁experien 5.9453125
cing 0.00844573974609375
▁chron 1.3330078125
ic 0.00959014892578125
▁pain 0.1361083984375
. 0.74365234375
▁This 3.265625
▁research 2.916015625
▁paper 6.51953125
▁a 2.06640625
ims 0.0031261444091796875
▁to 0.1263427734375
▁analyze 3.2578125
▁levels 9.53125
▁of 0.0517578125
▁de 0.6630859375
pression 0.03204345703125
▁and 0.2305908203125
▁anx 0.052642822265625
iety 0.008941650390625
▁among 0.76904296875
▁people 3.5546875
▁receiving 0.95849609375
▁ther 7.83203125
apy 0.264404296875
▁by 5.11328125
▁comparing 7.96484375
▁the 1.0146484375
▁effects 2.109375
▁of 0.044586181640625
▁ph 2.541015625
arma 0.09295654296875
ce 0.00482940673828125
ut 0.005115509033203125
ical 0.005741119384765625
▁op 0.31396484375
io 0.189697265625
ids 0.0709228515625
▁and 0.302001953125
▁MM 1.556640625
. 0.98486328125
<0x0A> 1.0986328125
The 1.421875
▁study 2.298828125
▁was 2.322265625
▁conducted 0.76904296875
▁in 1.5625
▁the 1.478515625
▁form 2.26171875
▁of 0.040252685546875
▁collection 10.0390625
▁and 1.7294921875
▁analysis 0.66455078125
▁of 0.055145263671875
▁statistical 4.3203125
▁data 0.12420654296875
. 0.94677734375
▁Part 4.984375
icip 0.1063232421875
ants 0.057037353515625
▁were 0.7744140625
▁rec 3.458984375
ru 0.005687713623046875
ited 0.00274658203125
▁for 4.21484375
▁six 7.71875
▁months 0.59423828125
▁at 3.76171875
▁two 2.5
▁major 5.62109375
▁pain 3.037109375
▁relief 5.30078125
▁cent 1.40234375
ers 0.09881591796875
▁in 0.6826171875
▁Israel 4.3359375
. 0.424560546875
▁The 1.2119140625
▁research 2.189453125
ers 1.474609375
▁used 2.6328125
▁The 7.70703125
▁De 4.1953125
pression 0.01727294921875
▁Module 10.0859375
▁of 0.9091796875
▁the 0.322509765625
▁Pat 2.3046875
ient 0.00841522216796875
▁Health 0.0880126953125
▁Question 0.0206298828125
naire 0.032012939453125
▁and 3.310546875
▁the 0.71142578125
▁General 1.810546875
ized 0.74755859375
▁An 0.0195159912109375
x 0.0011873245239257812
iety 0.0049591064453125
▁Dis 0.65234375
order 0.038970947265625
▁Sc 1.185546875
ale 0.0828857421875
▁to 1.7548828125
▁interview 6.98046875
▁participants 1.9658203125
, 3.7421875
▁evaluate 5.703125
▁their 0.73583984375
▁answers 6.50390625
, 1.0087890625
▁and 0.1666259765625
▁conduct 4.4375
▁the 2.298828125
▁study 2.357421875
. 0.2275390625
▁To 5.171875
▁specifically 10.109375
▁evaluate 2.64453125
▁and 4.46484375
▁compare 0.83154296875
▁the 0.32763671875
▁p 8.6015625
Z 10.3359375
rob 12.6875
abilities 4.30859375
▁of 0.302978515625
▁de 0.90673828125
pression 0.0284881591796875
▁or 5.828125
▁anx 0.06524658203125
iety 0.005123138427734375
▁among 1.28515625
▁the 2.63671875
▁diverse 8.90625
▁groups 1.685546875
, 1.8251953125
▁the 1.0283203125
▁study 2.791015625
▁used 1.6162109375
▁multiple 4.67578125
▁log 3.66796875
istic 0.05255126953125
▁regression 0.12890625
▁analysis 0.6484375
▁and 2.5234375
▁chose 9.2578125
▁medical 7.50390625
▁mar 0.52685546875
iju 0.02728271484375
ana 0.007228851318359375
▁as 0.7734375
▁the 1.0791015625
▁control 2.603515625
▁group 0.5703125
. 0.2841796875
<0x0A> 0.90771484375
This 3.4375
▁type 5.87109375
▁of 0.033203125
▁study 1.8662109375
▁is 1.21484375
▁the 3.302734375
▁most 1.75390625
▁reve 9.1484375
aling 0.014617919921875
▁and 1.0322265625
▁inclus 6.79296875
ive 0.009368896484375
, 2.25390625
▁as 1.95703125
▁it 0.320556640625
▁contains 5.00390625
▁direct 6.46875
▁responses 4.91796875
▁from 0.85302734375
▁a 3.97265625
▁large 0.97314453125
▁number 0.443115234375
▁of 0.01126861572265625
▁participants 1.3203125
. 0.6328125
▁All 4.65625
▁tools 9.046875
▁in 4.42578125
▁the 0.69921875
▁form 3.37109375
▁of 0.04583740234375
▁question 1.8056640625
na 0.03399658203125
ires 0.0023250579833984375
▁and 2.15234375
▁scales 3.208984375
▁have 3.61328125
▁already 4.49609375
▁been 0.1759033203125
▁used 1.9384765625
▁and 2.1796875
▁proved 4.078125
▁their 1.6455078125
▁effic 3.673828125
acy 0.00135040283203125
▁for 3.55078125
▁collect 4.68359375
ing 0.018157958984375
▁analyt 8.203125
ical 0.269775390625
▁data 0.2568359375
. 0.422607421875
▁It 3.5234375
▁helps 4.84765625
▁to 0.8662109375
▁system 7.31640625
at 1.0654296875
ize 0.0281982421875
▁and 1.6298828125
▁class 4.15234375
ify 0.006061553955078125
▁distinct 9.3203125
▁kinds 6.18359375
▁of 0.034149169921875
▁information 3.45703125
▁for 3.9375
▁subsequent 3.970703125
▁un 7.9296875
comp 5.7109375
licated 0.087646484375
▁services 11.6953125
. 0.6591796875
▁Thus 4.33984375
, 0.0293121337890625
▁research 4.53515625
ers 0.607421875
▁can 1.349609375
▁compare 3.869140625
▁the 0.96142578125
▁effects 2.97265625
▁of 0.10540771484375
▁medic 4.37109375
ations 0.84521484375
▁on 1.7939453125
▁patients 2.07421875
▁of 4.34375
▁diverse 3.974609375
▁age 2.71875
▁groups 0.71044921875
, 0.908203125
▁background 5.1015625
s 0.2335205078125
, 0.08477783203125
▁physical 5.43359375
▁conditions 1.3974609375
, 0.10528564453125
▁emot 5.55859375
ional 0.08966064453125
▁states 1.29296875
, 0.1153564453125
▁and 0.46533203125
▁so 3.15234375
▁on 0.314208984375
. 0.09136962890625
<0x0A> 0.73388671875
The 1.1630859375
▁analysis 4.4765625
▁of 0.521484375
▁any 8.6015625
▁human 5.94921875
▁reaction 4.6484375
▁has 4.51171875
▁a 1.712890625
▁high 4.5625
▁potential 3.318359375
▁of 1.6708984375
▁subject 6.171875
iveness 3.810546875
▁and 1.33203125
▁bias 2.296875
, 1.8779296875
▁especially 2.57421875
▁regarding 4.54296875
▁people 4.48828125
▁in 3.900390625
▁severe 4.47265625
▁pain 0.29345703125
▁and 2.625
▁un 5.390625
stable 1.7802734375
▁emot 0.9873046875
ional 0.220458984375
▁condition 2.728515625
. 0.07672119140625
▁Perhaps 8.84375
▁some 5.00390625
▁patients 2.349609375
▁tend 5.79296875
▁to 0.0239105224609375
▁ex 2.388671875
agger 0.0038318634033203125
ate 0.01020050048828125
▁their 0.73583984375
▁de 5.03125
press 1.892578125
ive 0.432373046875
▁state 3.107421875
▁or 1.75390625
▁vice 7.421875
▁vers 0.0273284912109375
a 0.0018529891967773438
, 1.0244140625
▁de 7.4921875
- 4.5625
emph 0.9375
as 0.01136016845703125
ize 0.1243896484375
▁serious 6.64453125
▁difficulties 5.96875
. 0.86767578125
▁Because 6.15625
▁the 2.32421875
▁survey 6.08203125
▁responses 6.5
▁were 1.611328125
▁thoroughly 8.0546875
▁anonymous 5.17578125
, 0.455810546875
▁the 1.453125
▁research 1.4677734375
ers 0.269775390625
▁were 1.44140625
▁unable 2.447265625
▁to 0.01047515869140625
▁carefully 8.8046875
▁analyze 1.53125
▁each 3.955078125
▁patient 2.4609375
’ 26.390625
s 0.88671875
▁reaction 3.51953125
▁and 2.48828125
▁compare 3.357421875
▁it 0.8427734375
▁to 1.2646484375
▁the 0.74560546875
▁actual 5.625
▁states 7.36328125
▁of 0.68408203125
▁condition 7.2578125
. 0.368896484375
▁More 6.82421875
▁accurate 3.94921875
▁answers 4.78125
▁could 2.46875
▁be 0.86865234375
▁obtained 0.93310546875
▁by 1.3896484375
▁professional 7.54296875
▁psych 2.23046875
olog 0.30126953125
ists 0.004726409912109375
▁via 8.171875
▁personal 3.888671875
▁communication 4.66015625
▁and 1.912109375
▁behavior 7.2109375
al 0.31884765625
▁analysis 2.232421875
. 0.2354736328125
▁However 2.759765625
, 0.00360107421875
▁this 1.9365234375
▁method 2.89453125
▁of 2.244140625
▁research 2.12890625
▁is 0.89111328125
▁way 7.98828125
▁more 1.6083984375
▁resource 6.63671875
- 0.4892578125
int 0.58642578125
ensive 0.00897979736328125
▁and 0.62255859375
▁energy 8.609375
- 0.1497802734375
consum 0.317626953125
ing 0.00382232666015625
. 0.61083984375
<0x0A> 0.6298828125
Part 5.66796875
icip 0.11529541015625
ants 0.1357421875
▁were 1.0322265625
▁rec 1.6904296875
ru 0.002899169921875
ited 0.0004949569702148438
▁for 1.1455078125
▁six 1.1767578125
▁months 0.0247802734375
▁at 0.427978515625
▁two 0.09906005859375
▁major 0.2900390625
▁pain 0.03509521484375
▁relief 0.0306549072265625
▁cent 0.019805908203125
ers 0.01248931884765625
▁in 0.055816650390625
▁Israel 0.0271759033203125
. 0.1357421875
▁All 3.53515625
▁patients 1.6376953125
▁experienced 5.46875
▁chron 1.880859375
ic 0.0036907196044921875
▁pain 0.1041259765625
▁for 3.357421875
▁at 0.7744140625
▁least 0.00373077392578125
▁ 1.12890625
3 1.4189453125
▁months 0.23681640625
. 1.029296875
▁The 1.466796875
▁study 1.9609375
▁included 2.17578125
▁ 1.09765625
8 2.947265625
9 2.76171875
0 3.650390625
▁participants 1.5048828125
, 1.2626953125
▁of 1.7841796875
▁which 0.39208984375
▁ 0.1455078125
4 1.6328125
7 2.466796875
4 2.796875
▁( 2.216796875
5 0.10711669921875
9 10.90625
%) 0.96435546875
▁were 0.4736328125
▁treated 4.59375
▁sole 7.2109375
ly 0.0004363059997558594
▁with 0.453369140625
▁op 0.74462890625
io 0.4150390625
ids 0.197998046875
, 1.1572265625
▁ 0.58740234375
3 1.0810546875
2 2.1015625
9 2.55078125
▁( 0.047698974609375
4 1.234375
1 1.240234375
%) 0.13037109375
▁were 1.3466796875
▁treated 0.52880859375
▁with 0.1761474609375
▁MM 0.70849609375
, 0.260498046875
▁and 0.1585693359375
▁ 0.141357421875
7 3.20703125
7 2.4296875
▁( 0.192626953125
8 3.84375
. 1.2509765625
6 2.7734375
%) 0.059661865234375
▁acquired 9.8125
▁both 1.12890625
▁( 7.00390625
Fe 10.0
ing 2.671875
old 0.0199737548828125
▁et 1.416015625
▁al 0.032562255859375
., 0.35498046875
▁ 0.0157623291015625
2 0.1458740234375
0 0.0011119842529296875
1 0.402099609375
7 2.111328125
). 0.1263427734375
▁The 1.3154296875
▁remaining 7.03515625
▁ten 8.2421875
▁participants 1.3203125
▁who 5.5078125
▁did 1.515625
▁not 0.00926971435546875
▁receive 1.767578125
▁ph 3.11328125
arma 0.056427001953125
ce 0.0027866363525390625
ut 0.0005788803100585938
ical 0.0033397674560546875
▁op 0.96533203125
io 0.09344482421875
ids 0.023651123046875
▁and 1.7099609375
▁medical 2.41015625
▁mar 0.053009033203125
iju 0.00962066650390625
ana 0.00026702880859375
▁were 1.2216796875
▁with 5.94921875
dra 0.198974609375
wn 0.0005364418029785156
▁from 0.264404296875
▁the 0.10955810546875
▁analysis 4.6875
▁in 4.82421875
▁the 1.2158203125
▁research 4.26171875
. 0.74609375
▁Therefore 4.76171875
, 0.00811767578125
▁it 3.744140625
▁is 0.8251953125
▁not 2.65625
▁possible 0.68994140625
▁to 0.02081298828125
▁compreh 6.625
ens 0.051239013671875
ively 0.0170745849609375
▁compare 1.8408203125
▁patients 4.875
▁taking 4.24609375
▁medic 3.87890625
ations 0.443603515625
▁with 0.95166015625
▁those 1.1796875
▁who 1.1455078125
▁do 1.7744140625
▁not 0.0111846923828125
. 0.80224609375
<0x0A> 0.63330078125
The 1.1640625
▁study 1.755859375
▁conducted 4.7578125
▁a 2.298828125
▁corre 14.8125
ation 11.6484375
▁type 7.14453125
▁of 0.46728515625
▁research 1.9609375
▁with 2.8046875
▁variable 7.83203125
▁measures 4.16796875
. 1.138671875
▁It 2.052734375
▁evaluated 4.71484375
▁the 0.6181640625
▁inter 7.12890625
dep 3.583984375
end 0.007843017578125
ence 0.0220794677734375
▁of 0.461669921875
▁various 3.951171875
▁factors 1.6611328125
▁that 2.748046875
▁affected 4.0546875
▁the 0.5400390625
▁physical 7.23828125
▁and 0.9521484375
▁emot 0.623046875
ional 0.0009613037109375
▁condition 1.24609375
▁of 0.146728515625
▁patients 0.640625
▁experien 4.921875
cing 0.0004100799560546875
▁chron 0.65576171875
ic 0.0007891654968261719
▁pain 0.0297393798828125
. 0.24267578125
▁For 3.814453125
▁example 1.0419921875
, 0.0134429931640625
▁the 1.2294921875
▁survey 5.32421875
▁showed 3.478515625
▁that 0.29736328125
▁the 1.7294921875
▁ratio 7.1640625
▁of 0.127197265625
▁female 4.43359375
▁patients 0.83544921875
▁was 1.8408203125
▁remark 9.5078125
ably 0.0022487640380859375
▁higher 0.56494140625
▁in 2.62890625
▁the 0.97607421875
▁op 4.4140625
i 3.69921875
ates 0.230712890625
▁group 0.265380859375
▁compared 2.748046875
▁to 0.11370849609375
▁the 0.5263671875
▁MM 0.4931640625
▁group 0.301513671875
. 0.51806640625
▁In 2.98046875
▁turn 4.15625
, 0.0036792755126953125
▁people 6.0390625
▁on 5.48046875
▁op 1.3818359375
i 0.47802734375
ates 0.00524139404296875
▁were 1.0478515625
▁more 0.962890625
▁likely 0.400146484375
▁to 0.0645751953125
▁report 3.259765625
▁major 6.08203125
▁de 0.43896484375
press 1.2744140625
ive 0.005542755126953125
▁dis 0.501953125
orders 1.4912109375
. 1.833984375
<0x0A> 2.662109375
The 1.140625
▁question 5.68359375
na 1.0322265625
ires 0.000530242919921875
▁used 2.041015625
▁different 7.99609375
▁variable 8.8125
▁measures 0.837890625
▁to 1.3671875
▁collect 2.40625
▁information 1.9638671875
. 1.642578125
▁For 1.896484375
▁example 0.1923828125
, 0.007541656494140625
▁it 4.06640625
▁included 2.642578125
▁compreh 8.671875
ensive 0.02947998046875
▁so 6.875
cio 0.07073974609375
- 0.58154296875
dem 0.107177734375
ographic 0.041778564453125
▁data 1.0234375
: 4.90625
▁gender 1.552734375
, 0.09136962890625
▁age 0.203857421875
, 0.09014892578125
▁country 4.33203125
, 1.4404296875
▁type 4.3046875
▁of 0.057220458984375
▁residence 3.88671875
▁( 3.4140625
urban 2.04296875
/ 2.974609375
r 0.06365966796875
ural 0.0017824172973632812
), 0.2396240234375
▁years 5.99609375
▁of 0.158447265625
▁education 0.66650390625
, 0.1439208984375
▁and 1.841796875
▁employ 3.625
ment 0.00530242919921875
▁status 0.452880859375
. 0.1746826171875
▁Pat 4.0703125
ients 0.0985107421875
▁were 1.1884765625
▁also 0.85693359375
▁asked 0.6064453125
▁about 1.1494140625
▁their 0.6044921875
▁medical 2.76171875
▁history 0.410400390625
▁over 8.8203125
▁the 0.1602783203125
▁years 3.9921875
▁and 1.775390625
▁the 1.853515625
▁current 3.3671875
▁presence 5.84375
▁of 0.056854248046875
▁any 2.65625
▁severe 4.671875
▁dise 1.5087890625
ases 0.00025463104248046875
▁such 4.1796875
▁as 0.005634307861328125
▁heart 2.40234375
▁failure 1.98828125
, 0.1942138671875
▁di 1.8408203125
ab 0.002391815185546875
etes 0.0043487548828125
, 0.12451171875
▁ar 3.76953125
th 0.125732421875
rit 0.0357666015625
is 0.01245880126953125
, 0.042572021484375
▁and 1.56640625
▁so 0.7216796875
▁on 0.0309906005859375
. 0.050750732421875
▁The 1.857421875
▁third 7.28515625
▁measure 3.86328125
▁of 2.052734375
▁the 0.93798828125
▁question 2.701171875
naire 0.222900390625
▁was 0.94189453125
▁indicated 9.59375
▁by 0.6259765625
▁information 6.7265625
▁on 1.578125
▁any 5.4375
▁twelve 13.6015625
- 1.1298828125
month 0.39404296875
▁and 5.8203125
▁lifetime 3.142578125
▁drug 4.71484375
▁and 3.568359375
▁alco 0.08343505859375
hol 0.00018894672393798828
▁consumption 2.59375
. 0.455322265625
▁In 3.4921875
▁addition 0.77197265625
, 0.130859375
▁the 1.1484375
▁record 7.95703125
▁included 1.8115234375
▁a 2.46484375
▁pain 6.296875
▁measurement 4.234375
▁scale 0.9921875
▁from 3.595703125
▁ 0.444091796875
0 0.43115234375
▁to 0.4091796875
▁ 0.007518768310546875
1 0.08331298828125
0 0.06976318359375
▁to 4.56640625
▁evaluate 1.51171875
▁dis 5.9609375
com 0.2105712890625
fort 0.0033054351806640625
▁feelings 7.36328125
▁during 3.2734375
▁the 0.890625
▁last 1.45703125
▁month 1.568359375
. 0.282958984375
<0x0A> 1.078125
Am 6.8828125
ong 0.0157318115234375
▁all 2.376953125
▁participants 2.083984375
▁in 3.490234375
▁the 0.1719970703125
▁study 0.37548828125
, 0.057281494140625
▁ 0.677734375
4 1.7841796875
2 2.7265625
. 1.767578125
2 2.291015625
% 0.1446533203125
▁suffered 4.87109375
▁from 0.1234130859375
▁de 1.763671875
pression 0.15869140625
, 1.0986328125
▁and 1.78515625
▁ 0.151123046875
3 1.705078125
7 2.224609375
% 2.72265625
▁experienced 2.291015625
▁excess 7.7578125
ive 0.0908203125
▁anx 0.27197265625
iety 0.0024051666259765625
. 0.34765625
▁The 1.4052734375
▁pl 11.1171875
ur 1.037109375
ality 0.00043320655822753906
▁of 0.2001953125
▁de 3.572265625
press 1.3427734375
ive 0.031585693359375
▁dis 1.853515625
orders 0.064453125
▁among 3.8359375
▁patients 1.16796875
▁in 3.638671875
▁the 0.35400390625
▁op 1.4130859375
i 0.87890625
ates 0.00693511962890625
, 7.078125
▁medical 2.86328125
▁mar 0.0244140625
iju 0.01108551025390625
ana 8.630752563476562e-05
, 0.10430908203125
▁and 0.06951904296875
▁mixed 6.23046875
▁OP 8.9296875
MM 5.5859375
▁groups 0.478759765625
▁number 8.1328125
ed 0.010528564453125
▁ 0.12152099609375
5 2.21484375
7 2.494140625
. 0.2044677734375
1 2.3671875
%, 0.2342529296875
▁ 0.0049591064453125
2 2.984375
2 2.431640625
. 0.1025390625
3 2.236328125
%, 0.11590576171875
▁and 0.034515380859375
▁ 0.0033130645751953125
5 3.2265625
1 2.57421875
. 0.1669921875
4 2.142578125
%, 0.384521484375
▁respectively 0.01157379150390625
. 0.280029296875
▁The 1.451171875
▁pl 4.63671875
ur 0.0226593017578125
ality 5.8531761169433594e-05
▁of 0.040496826171875
▁anx 0.9453125
iety 0.01374053955078125
▁contained 10.96875
▁ 0.56884765625
4 1.5859375
8 2.3828125
. 0.0626220703125
4 2.30859375
% 0.509765625
▁among 1.4716796875
▁OP 6.5
▁patients 9.203125
, 0.28076171875
▁ 0.0999755859375
2 1.505859375
1 2.416015625
. 0.131591796875
5 2.4296875
% 0.01166534423828125
▁among 0.435302734375
▁MM 0.3076171875
▁patients 0.2449951171875
, 0.01153564453125
▁and 0.0137481689453125
▁ 0.03839111328125
3 1.2490234375
8 2.6484375
. 0.1539306640625
7 2.28515625
% 0.013458251953125
▁among 0.22607421875
▁OP 4.28125
MM 0.2298583984375
▁participants 3.5390625
. 0.2236328125
▁Pat 5.69921875
ients 0.0228424072265625
▁who 2.419921875
▁took 2.88671875
▁strong 8.203125
▁op 1.1494140625
i 1.40625
ates 0.00394439697265625
▁were 1.759765625
▁t 8.71875
ended 1.0400390625
▁to 0.01422882080078125
▁place 10.359375
▁their 3.720703125
▁pain 2.595703125
▁on 3.37109375
▁a 0.82421875
▁scale 2.201171875
▁of 0.64990234375
▁ 0.34619140625
9 2.865234375
▁to 1.337890625
▁ 0.016204833984375
1 0.0226898193359375
0 0.09149169921875
▁( 2.52734375
Fe 1.6630859375
ing 0.00981903076171875
old 0.0007996559143066406
▁et 0.029083251953125
▁al 0.0024089813232421875
., 0.0081329345703125
▁ 0.0023403167724609375
2 0.0005593299865722656
0 0.00010156631469726562
1 0.0019388198852539062
7 0.01346588134765625
). 0.051544189453125
▁They 4.64453125
▁were 1.2685546875
▁also 1.3330078125
▁an 8.828125
gu 4.125
ished 0.04132080078125
▁em 8.1875
otion 0.0218963623046875
ally 0.056854248046875
▁and 1.0859375
▁react 6.94921875
ed 0.05487060546875
▁rad 9.5
ically 0.01468658447265625
▁neg 5.33984375
atively 0.0018110275268554688
▁o 8.328125
▁almost 7.5859375
▁all 1.462890625
▁survey 8.3359375
▁questions 0.7333984375
. 0.2822265625
▁Pat 4.11328125
ients 0.007740020751953125
▁who 1.1474609375
▁took 1.5126953125
▁only 5.609375
▁MM 0.7802734375
▁or 3.126953125
▁mixed 3.478515625
▁medic 2.630859375
ations 0.317626953125
▁course 12.6875
▁had 2.48046875
▁a 1.302734375
▁significantly 2.71484375
▁more 4.00390625
▁stable 3.35546875
▁emot 1.2724609375
ional 0.0105438232421875
▁state 0.7802734375
▁and 1.388671875
▁cop 5.44921875
ed 1.01953125
▁with 0.6826171875
▁pain 1.3359375
▁more 1.583984375
▁manage 6.80859375
able 2.44140625
. 0.481201171875
<0x0A> 0.65966796875
One 5.12890625
▁of 0.54638671875
g 18.28125
▁the 0.74609375
▁major 2.744140625
▁limitations 2.640625
▁is 4.08984375
▁the 0.56982421875
▁ins 4.94140625
u 0.0347900390625
fficient 0.1380615234375
ly 4.6875
▁high 3.111328125
▁response 2.900390625
▁rate 0.1229248046875
, 2.650390625
▁ 4.44921875
5 1.916015625
7 2.03125
% 2.046875
▁instead 7.40625
▁of 0.0264129638671875
▁ 0.72265625
7 1.525390625
0 1.5166015625
% 1.12109375
▁( 1.66796875
Fe 0.256103515625
ing 0.0091400146484375
old 0.0021533966064453125
▁et 0.00780487060546875
▁al 0.005481719970703125
., 0.0075836181640625
▁ 0.0047760009765625
2 0.00061798095703125
0 0.00011849403381347656
1 0.0015239715576171875
7 0.009246826171875
). 0.03662109375
▁It 2.69921875
▁can 3.248046875
▁be 0.37353515625
▁f 9.796875
T 8.359375
air 10.359375
ly 0.51171875
▁explained 1.515625
▁by 0.138427734375
▁the 0.41943359375
▁weak 8.125
▁focus 7.01953125
▁of 0.488525390625
▁respond 6.3359375
ents 0.1446533203125
▁who 3.416015625
▁have 4.30078125
▁overcome 8.046875
▁severe 2.4375
▁pain 0.52099609375
▁sens 8.625
ations 1.18359375
▁and 1.23828125
▁de 4.2421875
press 2.060546875
ive 0.252197265625
▁episodes 4.3515625
. 0.5673828125
▁It 3.365234375
▁is 0.8359375
▁not 2.6328125
▁clear 4.14453125
▁how 1.669921875
▁to 3.88671875
▁use 5.3515625
▁these 3.0390625
▁statistics 3.609375
, 2.626953125
▁as 1.4306640625
▁they 1.3759765625
▁still 6.2265625
▁may 4.85546875
▁be 1.3408203125
▁relevant 5.921875
▁for 1.3447265625
▁the 1.90234375
▁overall 4.72265625
▁analysis 3.212890625
. 1.1572265625
